Brief: Puma Biotechnology Q2 Adjusted EPS USD -0.05
01/08/2024 21:05
Aug 01 (Reuters) - Puma Biotechnology Q2 operating income USD -2.2 million. * Q2 product revenue USD 44.4 million * Q2 net income USD -4.5 million * Q2 adjusted net income USD -4.2 million * Q2 EPS USD -0.09
Recent news on Puma Biotechnology
See all newsBrief: Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(C)(4)
Brief: Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Puma Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Corrected: Puma Biotechnology lifts 2026 outlook as Q2 revenue rises on NERLYNX demand
Brief: Puma Biotechnology Q2 Adjusted EPS USD 0.2